NEW YORK, April 20, 2023 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Amgen Inc. Shareholders who purchased shares of AMGN during the class listed period are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: Amgen Inc. Loss Submission Form PERIOD CLASS: This lawsuit is on behalf of all persons who purchased or otherwise acquired Amgen common stock between July 29, 2020 and April 27, 2022, inclusive. ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (a) the US government claimed Amgen owed more than $3 billion in back taxes for tax years 2010, 2011, and 2012; (b) the US government claimed Amgen owed more than $5 billion in back taxes for tax years 2013, 2014, and 2015; (c) the US government would likely claim Amgen owed materially more to the US government than investors had been led to believe for subsequent tax years for which the Company had used the same profit allocation treatment between its US and Puerto Rico operations; (d) Amgen had not taken sufficient accruals to account for its outstanding tax liabilities; (e) Amgen had failed to comply with Accounting Standards Codification Topic 450 and other rules and regulations regarding the preparation of its periodic filings with the US Securities and Exchange Commission; and (f) Amgen’s refusal to pay taxes claimed by the US government exposed the Company to a substantial risk of severe financial penalties imposed by the Internal Revenue Service.…